NCT03756311 2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available
Clinical Trials
12 trialsNCT03523338 2025-12-10
An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc.
No longer available
NCT05002465 2023-09-11
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
University of Texas Southwestern Medical Center
No longer available
NCT05415228 2023-05-18
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer
University of Michigan
No longer available
NCT04854369 2023-04-11
Firefly
Tulane University
No longer available
NCT03501940 2022-01-21
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
Stanford University
No longer available
NCT04800068 2022-01-21
Expanded Access [Ga-68] PSMA-11 PET Imaging
Mayo Clinic
No longer available
NCT02826395 2020-07-24
C11 Sodium Acetate PET/CT Imaging of PCa
Jonsson Comprehensive Cancer Center
No longer available
NCT03554434 2020-03-02
An Expanded Access Program for AM0010 (Pegilodecakin)
Eli Lilly and Company
No longer available
NCT01777061 2018-05-16
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
University of Kansas Medical Center
No longer available
NCT01516762 2014-07-14
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Bayer
No longer available
NCT00636259 2008-06-11
Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer
AstraZeneca
No longer available